Cargando…
Advances in experimental animal models of hepatocellular carcinoma
Hepatocellular carcinoma (HCC) is a common malignant tumor with insidious early symptoms, easy metastasis, postoperative recurrence, poor drug efficacy, and a high drug resistance rate when surgery is missed, leading to a low 5‐year survival rate. Research on the pathogenesis and drugs is particular...
Autores principales: | Li, Jing, Wang, Xin, Ren, Mudan, He, Shuixiang, Zhao, Yan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10417182/ https://www.ncbi.nlm.nih.gov/pubmed/37248746 http://dx.doi.org/10.1002/cam4.6163 |
Ejemplares similares
-
Efficacy and Safety of Radiofrequency Ablation Combined with Transcatheter Arterial Chemoembolization for Hepatocellular Carcinomas Compared with Radiofrequency Ablation Alone: A Time-to-Event Meta-Analysis
por: Wang, Xin, et al.
Publicado: (2016) -
Long non‐coding RNA SNAI3‐AS1 promotes the proliferation and metastasis of hepatocellular carcinoma by regulating the UPF1/Smad7 signalling pathway
por: Li, Yarui, et al.
Publicado: (2019) -
Circ_0003570 Suppresses the progression of hepatocellular carcinoma through miR-182-5p/STARD13 regulatory axis
por: Zhang, Xu, et al.
Publicado: (2022) -
Long non-coding RNA SNHG5 promotes human hepatocellular carcinoma progression by regulating miR-26a-5p/GSK3β signal pathway
por: Li, Yarui, et al.
Publicado: (2018) -
TQ inhibits hepatocellular carcinoma growth in vitro and in vivo via repression of Notch signaling
por: Ke, Xiquan, et al.
Publicado: (2015)